We have previously reported that myeloid-derived suppressor cells (MDSC), which are a heterogeneous population of immunosuppressive immature myeloid cells, expanded during chronic Staphylococcus aureus infection and promoted bacterial persistence by inhibiting effector T cells. Two major MDSC subsets, including monocytic MDSC and granulocytic MDSC, have been described to date. Here, we identified a new subset of MDSC (Eo-MDSC) in S. aureus-infected mice that phenotypically resembles eosinophils. Eo-MDSC exhibit eosinophilic cytoplasmic granules and express CD11b, the eosinophil marker Syglec-F, variable levels of CCR3, and low levels of interleukin-5Rα. Furthermore, Eo-MDSC accumulated at the site of infection and exerted a potent immunosuppressive effect on T-cell responses that was mediated by nitric oxide-dependent depletion of l-arginine. Increases in the number of Eo-MDSC by adoptive transfer caused a significant exacerbation of infection in S. aureus-infected mice. This study sheds new light on the heterogeneity and complexity of MDSC during chronic infection.
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature myeloid hematopoietic precursors that exhibit potent suppressive activities on T-cell responses [1] . Although MDSC appear in many pathological conditions associated with sustained demand of myeloid cells, such as cancer, chronic infections, and autoimmunity [2] , their specific biological functions are still unclear. Whereas expansion of MDSC during chronic infection may be an important mechanism protecting from the harmful effect of unremitting inflammation [2] , it can also facilitate bacterial persistence by inhibiting protective T-cell responses [3] . This is particularly apparent in the case of Staphylococcus aureus infections, an important human pathogen notorious for its capacity to develop antibiotic resistance [4] and for causing difficult-to-treat chronic infections [5] . Using a murine model of chronic abscess, we reported that CD4 + T cells, which are major effector cells during S. aureus infection, lost their functionality with the progression of infection towards chronicity [6] . In further studies, we demonstrated that MDSC were responsible for the observed T-cell dysfunction and probably for their failure to promote sterilizing immunity [7] . A similar situation was reported in S. aureus orthopedic biofilm infection [8] .
Although MDSC have been broadly classified into two different subsets, namely monocytic CD11b + Ly6C + Ly6G low (M-MDSC) and granulocytic CD11b + Ly6C low L6G + (PMN-MDSC) [9] , MDSC are phenotypically and functionally highly heterogeneous and most probably encompass multiple cell subsets with distinct phenotypic and functional characteristics. In the study presented here, we have identified a novel subset of MDSC in S. aureus-infected mice, which expanded with the progression of infection towards chronicity. This novel MDSC subset was termed Eo-MDSC because they depicted phenotypic features typical of immature eosinophils, including large eosinophilic granules in the cytoplasm and expression of CD11b, the eosinophil marker Syglec-F, variable levels of CCR3, and low levels of IL-5Rα. Furthermore, Eo-MDSC exerted a potent inhibitory effect on both naive and antigen-specific T-cell responses and had a negative impact on the course of S. aureus infection.
model, C57BL/6 mice were infected intravenously with 4 × 10 7 colony forming units (CFU) of S. aureus strain SH1000. It is known that S. aureus strain SH1000 produces kidney abscesses after intravenous inoculation [6] . For the model of chronic osteomyelitis, C57BL/6 mice were infected intravenously with 10 6 CFU of S. aureus strain 6850. This strain has a tropism for bones and osteomyelitis is generated after hematogenous bacterial seeding [10] .
Animal experiments were performed in strict accordance with the German regulations of the Society for Laboratory Animal Science and the European Health Law of the Federation of Laboratory Animal Science Associations. All experiments were approved by the ethics board Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit, Oldenburg, Germany (permit N. 33.9-42502-04-13/1195).
Flow Cytometry Analysis and Cell Sorting
Spleen cells were stained with antibodies against CD11b (BioLegend), Ly6C (BioLegend), Ly6G (Miltenyi Biotec), Siglec-F (BD Biosciences), CCR3 (Miltenyi Biotec), or interleukin-5Rα (IL-5Rα) (Miltenyi Biotec) for 30 minutes at 4°C. Cells were analyzed using a BD LSR II flow cytometer (BD Biosciences).
For cell sorting, a FACSAria II cell sorter (BD Biosciences) was used. The purity of the sorted cell populations was > 90% (Supplementary Figure 1) . Morphological characterization of MDSC subsets was performed on cytospin preparations of FACSorted MDSC subtypes after May-Grunwald-Giemsa staining.
Proliferation Assay
MDSC isolated from the spleen of S. aureus-infected mice at day 15 of infection or ex vivo matured bone marrow-derived eosinophils were added at indicated ratios to 5 × 10 5 splenocytes from either naive C57BL/6 mice stimulated with 2 µg/mL of anti-CD3/anti-CD28 antibodies (Sigma-Aldrich) or from OT-II/Thy1.1 transgenic mice stimulated with 1 µg/mL of OVA 323-339 peptide (provided by W. Tegge, Helmholtz Centre for Infection Research) in HL-1 medium (Biowhittaker) containing 10% FCS. After 2 days of incubation, the cells were pulsed with 1 µCi 3 H-thymidine (Amersham) and harvested 18 hours later on Filtermats A (Wallac) using a cell harvester (Inotech). The amount of 3 H-thymidine incorporation was measured in a gamma scintillation counter (Wallac 1450; MicroTrilux).
In some experiments, 1000 U/mL catalase (Roth), 1000 U/ mL superoxide dismutase (SOD; Sigma-Aldrich), 0.5 mM N-ω-hydroxy-nor-l-arginine (Nor-NOHA; Cayman Chemicals), 0.5 mM l-N G -monomethyl arginine citrate (l-NMMA; Calbiochem) or 150 µM l-arginine (Sigma-Aldrich) were added from the beginning of the culture.
Bone Marrow Isolation and Culture
Ex vivo production of mature eosinophil from unselected bone marrow progenitors was performed as previously described [11] . Briefly, bone marrow cells were collected from the mouse femurs and tibia by flushing with RPMI medium and incubated in RPMI 1640 media containing 20% FCS, 100 U/mL penicillin, 10 μg/mL streptomycin, 2 mM glutamine, 25 mM HEPES, 1 × nonessential amino acids, 1 mM sodium pyruvate, and 50 μM β-mercaptoethanol, and supplemented with 100 ng/mL stem-cell factor (SCF; PeproTech) and 100 ng/mL FLT3-ligand (FLT3-L; PeproTech) from day 0 to day 4. On day 4, the media containing SCF and FLT3-L was replaced with media containing 10 ng/mL recombinant mouse interleukin-5 (rIL-5; PeproTech) alone. On day 8, the cells were moved to new flasks and maintained in medium supplemented with 10 ng/mL rIL-5. The media was replaced each 2 days with fresh media containing 10 ng/mL rIL-5, and the differentiated eosinophils (>90%) were used for experiments at day 15-18 of culture.
Histology
Kidneys were removed from infected mice, fixed in 10% formalin, and embedded in paraffin. Tissue slides of kidney samples (2 µm thick) were stained with H&E and examined under light microscopy.
Adoptive Transfer Experiments
Eo-MDSC isolated from donor mice (day 15 of infection) or ex vivo matured bone marrow-derived eosinophils were injected (2 × 10 6 cells/mouse) into the tail vein of S. aureus-infected recipient mice at day 7 of infection. Mice were sacrificed at day 3 after adoptive cell transfer and the amount of bacteria in the target organ determined by plating.
Statistical Analyses
All data were analyzed with GraphPad Prism 7.0. Comparisons between several groups were made using a parametric ANOVA with Tukey post-test. Comparison between two groups was performed using a t test. The P values < .05 were considered significant.
RESULTS

Phenotypic Characterization of Eo-MDSC Subset in the Spleen of
S. aureus SH1000-Infected Mice
Phenotypic analysis of MDSC in the spleen of mice at day 15 after intravenous inoculation with S. aureus SH1000 identified 3 different populations based on the expression levels of Ly6C and Ly6G ( Figure 1A ): Ly6C low Ly6G + (R1), Ly6C + Ly6G low (R2), and Ly6C low Ly6G low (R3). The different subsets in R1, R2, and R3 were more apparent when the analysis was performed in Figure 1B , right panels). The cell population in R3 was a novel and not yet characterized MDSC subset, which we termed Eo-MDSC because they exhibited considerable high side scatter (SSC) profile, a feature associated with high cell granularity, and expressed Siglec-F, which is a receptor exclusively expressed by eosinophils [12] (Figure 2A ). Eo-MDSC greatly expanded with the progression of S. aureus in a similar way to M-MDSC and PMN-MDSC ( Figure 2B ). The 3 MDSC subsets were still present in the spleen of S. aureus SH1000-infected mice at day 20 and day 30 of infection, although the proportions of the different MDSC populations changed over time (Supplementary Figure 2) . Expansion of Eo-MDSC was not limited to the chronic renal abscess model but was also observed in a model of S. aureus chronic osteomyelitis induced after infection with S. aureus strain 6850 (Supplementary Figure  3) .
As MDSC are believed to be arrested at an immature state of cell differentiation [1] , we next investigated the maturation stage of the Eo-MDSC present in the spleen of S. aureus SH1000-infected mice at increasing times of infection. Although immature and mature eosinophils are morphologically almost indistinguishable, some markers such as the chemokine receptor CCR3 and the alpha subunit of the IL-5 receptor (IL-5Rα) have been reported to be expressed at different levels by murine eosinophils at different stages of development [13] . By combining Siglec-F, CCR3, and IL-5Rα markers, we were able to identify 3 cell subpopulations within the Siglec-F + cells in the spleen of S. aureus-infected mice at day 15 of infection, namely CCR3 − IL-5Rα low (G1), CCR3 + IL5-Rα low (G2), and CCR3 + IL-5Rα high (G3) ( Figure 2C , left panels). Because eosinophil maturation in adult mice has been shown to proceed from CCR3 − to CCR3 + cells and both populations exhibit low but equal expression of IL-5Rα [14] , the 2 different subpopulations of Siglec-F + cells in G1 and G2 may represent eosinophil immature precursors at different stages of differentiation. The small subpopulation in G3 ( Figure 2C , left panels) may represent mature eosinophils because the gated cells displayed high expression levels of CCR3 and IL-5Rα comparable to those expressed by phenotypically mature eosinophils generated ex vivo from unselected bone marrow progenitors (Supplementary Figure 4) . We then investigated whether Eo-MDSC developed into mature eosinophils with the progression of infection by measuring the levels of CCR3 and IL-5Rα expression within the Siglec-F + cell population over time. Although a transition from CCR3 − (G1) to CCR3 + (G2) was observed within the Siglec-F + population, the levels of IL-5Rα expression within the Siglec-F + CCR3 + subpopulation (G2) remained low at day 20 ( Figure 2C , middle panels) and day 30 ( Figure 2C , right panels) of infection and did not reach the levels observed in mature eosinophils generated ex vivo from bone marrow (Supplementary Figure 4) . Furthermore, the small population in G3 detected at day 15 of infection ( Figure 2C , left panels), which may represent mature eosinophils, was undetectable at day 20 ( Figure 2C , middle panels) and day 30 ( Figure 2C , right panels) of infection. Together, these observations suggest that Eo-MDSC are arrested at a premature stage of differentiation during the course of S. aureus infection.
Eo-MDSC are Potent Inhibitors of T-Cell Responses
As the hallmark of MDSC is their immunosuppressive effect, we next investigated the suppressive capacity of the infection-associated Eo-MDSC by coculturing Eo-MDSC purified from the spleen of S. aureus SH1000-infected mice at day 15 of infection at different ratios with splenocytes from uninfected C57BL/6 mice stimulated with anti-CD3/anti-CD28 antibodies. Cocultures using ex vivo-differentiated bone marrow mature eosinophils were included for comparison. Eo-MDSC but not mature eosinophils suppressed T-cell proliferation in a ratio-dependent manner ( Figure 3A , left panel). Additionally, Eo-MDSC were also potent inhibitors of antigen-specific T-cell responses as demonstrated by the significant suppression of OT-II splenocytes proliferation stimulated with the cognate peptide OVA 323-339 ( Figure 3A , right panel). This inhibitory effect was not observed when OT-II splenocytes were cocultured with bone marrow-derived mature eosinophils ( Figure  3A , right panel). The inhibitory activity of the different MDSC subsets was additive ( Figure 3B ), suggesting that all MDSC subsets may contribute to the overall inhibitory effect on T-cell responses.
We also determined if the CCR3 + and CCR3 − subpopulations identified within Eo-MDSC differed in their capacity to inhibit T-cell responses. For this purpose, Siglec-F + CCR3 − and Siglec-F + CCR3 + cells were purified from the spleen of S. aureus SH1000-infected mice at day 15 of infection by sorting and cocultured with splenocytes from uninfected C57BL/6 mice stimulated with anti-CD3/anti-CD28 antibodies. Despite the different levels of CCR3 expression, both Siglec-F + CCR3 − and Siglec-F + CCR3 + subpopulations exerted a robust inhibitory effect on T-cell proliferation ( Figure 3C ).
Eo-MDSC Suppress T-Cell Responses via Nitric Oxide-Dependent
Depletion of l-Arginine
The mechanisms mediating the immunosuppressive activity of MDSC are highly pleiotropic and have been linked to either the depletion of l-arginine by the enzymatic activity of nitric oxide synthase (NOS) and arginase-1 or to the generation of reactive oxygen species (ROS) initiated by NADPH oxidase 2 (gp91phox) [1] . To determine the specific mechanisms by which Eo-MDSC impaired T-cell responses, we performed the suppression assays in the presence of inhibitors that block each specific pathway. Addition of the ROS inhibitors catalase and SOD or the arginase-1 inhibitor NorNOHA to the Eo-MDSC:splenocytes cocultures did not affect the immunosuppressive effect of Eo-MDSC ( Figure 4A ). In contrast, addition of the NOS inhibitor l-NMMA significantly restored T-cell proliferation ( Figure 4A ). These findings indicated that Eo-MDSC suppressed T-cell responses via NOS. The addition of different inhibitors in combination did not significantly enhance the restoration of T-cell proliferation over the levels observed after treatment with l-NMMA alone ( Figure 4A ). Because NOS-mediated depletion of l-arginine, an amino acid that is critical for T-cell receptor-mediated signaling, has been proposed to be an important inhibitory mechanism used by MDSC to inhibit T-cell responses [1] , we determined the effect of supplementing the Eo-MDSC:splenocytes cocultures with excess of l-arginine. As shown in Figure 4B , addition of exogenous l-arginine resulted in significant recovery of T-cells proliferative responses. These results demonstrated that NOSmediated depletion of l-arginine is likely to be the main mechanism mediating the immunosuppressive effect of Eo-MDSC.
Increasing the Number of Eo-MDSC by Adoptive Cell Transfer Exacerbates Infection in Recipient Mice
In order to better understand the functional role of Eo-MDSC during S. aureus infection, we first determined whether Eo-MDSC are primarily a systemic response to persistent infection or are also able to infiltrate and accumulate at the site of infection. For this purpose, tissue sections from kidneys isolated from S. aureus SH1000-infected mice at day 15 of infection were stained with H&E and analyzed by light microscopy. Microscopy photographs depicted in Figure 5A confirmed the presence of numerous eosinophilic cells within the inflammatory infiltrate in the infected kidneys. Eosinophilic cells were totally absent in the kidneys of uninfected mice (data not shown). These observations indicate that Eo-MDSC may exert not only systemic but also site-specific suppression of T-cell responses.
To further investigate the effect of Eo-MDSC on the host response during S. aureus infection, we examined the effect of increasing Eo-MDSC in mice infected with S. aureus SH1000 during the acute phase of infection (day 7) using an adoptive cell transfer approach. As shown in Figure 5B , transferred Eo-MDSC caused a significant exacerbation of infection in recipient mice compared with untreated mice or with mice receiving mature eosinophils. Adoptive transfer of Eo-MDSC in mice infected with S. aureus 6850 also resulted in an increased amount of bacteria in the bones (Supplementary Figure 5) . However, these differences did not reach statistic significance. 
Eo-MDSC Catalase The results of these experiments demonstrated that Eo-MDSC damped the host immune defenses against S. aureus during in vivo infection.
DISCUSSION
Interest in MDSC as potential targets for therapeutic manipulation is increasing [1] . However, more information is required about their different phenotypes and functions before targeting this highly heterogeneous cell population for therapeutic purposes. In this study, we have identified a novel subset of MDSC that exhibits an immature eosinophil phenotype and we have termed Eo-MDSC. The Eo-MDSC expanded in the spleen and accumulated at the site of infection in the kidneys of S. aureus-infected mice during the chronic phase of infection. Furthermore, Eo-MDSC had a negative impact on the course of infection, most probably due to their inhibitory effect on protective T-cell responses. Eo-MDSC expressed CD11b and intermediate levels of Ly6C and Ly6G and differed from the well-characterized M-MDSC and PMN-MDSC subsets in their expression of the eosinophil marker Syglec-F, the chemokine receptor CCR3 which mediates eosinophil migration toward gradients of eotaxins [15] , the eosinophil differentiation marker IL-5Rα [16] , and in the high amount of eosinophilic granules present in their cytoplasm. Eosinophils are innate immune cells that play a fundamental role in host defense and immunity [16, 17] . They can secrete cytokines, chemokines, and growth factors and can also stimulate T and B-cell responses [16] [17] [18] . In contrast to the reported positive costimulatory effect of mature eosinophils for both primed and naive T cells [19] , the immature Eo-MDSC identified in this study were potent suppressors of T-cell responses. The immunosuppressive effect of Eo-MDSC was mediated by the depletion of l-arginine from the microenvironment by the activity of NOS. l-Arginine depletion has profound effects on T-cell function, causing down-regulation of the T-cell receptor z-chain [20] and cell-cycle arrest [21] . Although we have identified this novel Eo-MDSC subset in the setting of chronic infection, some indirect evidence suggests that they might also appear in response to tumors. In this regard, cells with eosinophil phenotype have been commonly described within the cellular infiltrate in many types of tumor [18, 22] . The possibility that some of these tumor-infiltrating eosinophils are Eo-MDSC deserves further investigation.
Like other hematopoietic lineages, eosinophils originate from the hematopoietic stem cell. In mouse hematopoiesis, eosinophil potential exists along with the granulocyte/monocyte differentiation pathway from hematopoietic stem cells, and at least a fraction of granulocyte/macrophage progenitors are bipotent for the eosinophil and the neutrophil lineages [23] . Because eosinophils develop from common granulocyte/monocyte progenitors in mice, it is likely that the same signals that arrest M-MDSC and PMN-MDSC in an immature phenotype and prevent their further development during chronic inflammatory conditions can also prevent Eo-MDSC from differentiating into mature eosinophils.
In summary, the novel Eo-MDSC identified in this study underscores the heterogeneity of MDSC and the need for a better characterization of the specific role of the different MDSC subsets before considering them as targets for therapeutic intervention.
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